Skip to content
Disclosery

EXANE DERIVATIVES: QCOM position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on QCOM, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 1,808 QCOM shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 1,808 shares
    Change vs previous 13F -4,399 shares

    0.13% of the 13F portfolio, value $230,930.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 6,207 shares
    Change vs previous 13F +389 shares

    0.27% of the 13F portfolio, value $948,560.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 5,818 shares
    Change vs previous 13F +3,583 shares

    0.26% of the 13F portfolio, value $1,063,972.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 2,235 shares
    Change vs previous 13F -55 shares

    0.07% of the 13F portfolio, value $288,282.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 2,290 shares
    Change vs previous 13F +1,051 shares

    0.08% of the 13F portfolio, value $323,309.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 1,239 shares
    Change vs previous 13F -400 shares

    0.05% of the 13F portfolio, value $164,287.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 1,639 shares
    Change vs previous 13F -281 shares

    0.08% of the 13F portfolio, value $249,696.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 1,920 shares
    Change vs previous 13F not available

    0.07% of the 13F portfolio, value $225,952.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).